Erika Kovacs-Bogdan

Erika Kovacs-Bogdan, Ph.D.

Erika Kovacs-Bogdan

Erika Kovacs-Bogdan is a senior alliance manager in the Cardiovascular Disease Initiative (CVDi). She is the alliance manager of the Broad-Bayer Cardiometabolic Risks and Precision Cardiology Lab collaborations. Previously, Kovacs-Bogdan was a research scientist and project team lead in the same team focusing on the characterization and validation of novel therapeutic candidates for treatment of heart disease.

Prior to joining the Broad Institute in 2015, Kovacs-Bogdan undertook postdoctoral training in the lab of Vamsi Mootha at Massachusetts General Hospital, and reconstituted the mitochondrial calcium uniporter in yeast to study its function. She joined the Broad Institute as a research scientist in the Thomas lab of the Broad Institute’s Cancer Program, and later joined the CVDi in May 2017.

Kovacs-Bogdan obtained a Ph.D. in biochemistry at Ludwig Maximilians University, Munich, Germany, in the lab of Prof. Juergen Soll. She also holds a M.S. in biology and chemistry from Eotvos Lorand University, Budapest, Hungary.

Contact Erika Kovacs-Bogdan via email at

October 2022